Grants and Contracts

Farley JF, Wang CC, Hansen RA, Voils CI, Maciejewski ML. (2011) “Continuity of Antipsychotic Medication Management for Medicaid Patients with Schizophrenia” Psychiatric Services. 62(7):747-752.

Chen SY, Hansen RA, Farley JF, Gaynes BN, Morrissey JP, Maciejewski ML. (2010) “Guideline-concordant antidepressant use among patients with major depressive disorder. General Hospital Psychiatry.” 32(4):360-367.

Maciejewski ML, Farley JF, Parker J, Wansink D. (2010) “Copayment Reductions Generate Greater Medication Adherence in Targeted Patients” Health Affairs. 29(11):2002-8.

Farley JF, Wang CC, Blalock SJ. (2010) The status of Ph.D. education in Economic, Social, and Administrative Sciences between 2005 and 2008. American Journal of Pharmacy Education. 74(7):Article 126.

Hansen RA, Farley JF, Droegge M, Maciejewski ML. (2010) “A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005.” Clinical Therapeutics.  32(7):1308-1319.

Farley JF, Dusetzina S. (2010) “Medicaid prescription drug utilization and expenditures following Part D.” Journal of Health Care for the Poor and Underserved. 21(2):715-728.

Farley JF. (2010) “Medicaid prescription cost containment and schizophrenia: a retrospective examination.” Medical Care. 48(5):440-447.

Domino ME, Farley JF. (2010) “Economic Grand Rounds: Did Medicare Part D improve access to medications?” Psychiatric Services. 61(2):118-120.

Maciejewski ML, Farley JF, Hansen RA, Wei D, Harman JS. (2010) “Part D plan enrollment by uninsured Medicare beneficiaries.” Medical Care. 48(2):183-186.

Chen SY, Hansen RA, Farley JF, Gaynes BN, Morrissey JP, Maciejewski ML. (2010) “Follow-up visits by provider specialty for patients with major depressive disorder initiating antidepressant treatment.” Psychiatric Services. 61(1):81-85.